Brief: Akari Therapeutics Provides Update On Development Of PAS-Nomacopan

Akari Therapeutics

11/07/2023 13:14

July 11 (Reuters) - Akari Therapeutics PLC  AKTX.O :
    * AKARI THERAPEUTICS PROVIDES UPDATE ON DEVELOPMENT OF
LONG-ACTING
PAS-NOMACOPAN FOR TREATMENT OF GEOGRAPHIC ATROPHY
    * AKARI THERAPEUTICS PLC - REMAINS ON TRACK FOR AN IND
SUBMISSION
IN FIRST HALF OF 2024 AND START OF CLINICAL TRIALS IN SECOND
HALF OF 2024
    * AKARI THERAPEUTICS PLC - HAS SELECTED WACKER BIOTECH GMBH
AS
MANUFACTURING PARTNER TO SUPPORT PRODUCTION OF PAS-NOMACOPAN FOR
USE IN CLINICAL TRIALS

Source text for Eikon:  ID:nGNE7Vl4gQ 
Further company coverage:  AKTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))